Cetirizine hydrochloride is a second-generation antihistamine used to relieve symptoms of seasonal allergies or hay fever such as sneezing, itchy/runny nose and red, watery eyes. As an oral medication, cetirizine hydrochloride effectively treats both indoor and outdoor allergies. It is widely used due to its high efficacy and reduced side effects compared to older antihistamines. The global Cetirizine Hydrochloride Market is estimated to be valued at US$ 2.3 billion in 2024 and is expected to exhibit a CAGR of 4.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

 

Market key trends:

Increased adoption of allergy care medicines has accelerated the growth of the cetirizine hydrochloride market. According to a recent report by the American College of Allergy, Asthma and Immunology, allergies affect over 50 million Americans. The rising prevalence of allergic rhinitis and other respiratory allergies has prompted more people to seek medical treatment. Increased awareness about available antihistamine medications and growing adoption of a preventive healthcare approach are strengthening the demand for cetirizine hydrochloride drugs. Moreover, availability of generic versions has made cetirizine hydrochloride affordable for common use in households, contributing to market expansion. To sustain increased demand, leading drug manufacturers are investing increasingly in R&D as well as capacity expansion of cetirizine hydrochloride production facilities. This ensures adequate supply of high quality drugs and supplements the market growth.

Segment Analysis

Cetirizine Hydrochloride Market is segmented on the basis of formulation which includes tablet, capsule, syrup and others. Among them, tablet segment dominates the market owing to high adoption of tablet dosage form for its ease of administration. Tablet forms have high patient compliance as compared to other forms.

 

Key Takeaways

The Global Cetirizine Hydrochloride Market share is expected to witness high growth during the forecast period.

Asia Pacific region is currently dominating the market and is expected to maintain its leading position over the projection period. Increasing cases of allergies due to changing lifestyle and growing environmental pollution are major factors fueling demand for antihistamine drugs like cetirizine hydrochloride in Asia Pacific countries.

 

Key players operating in the Cetirizine Hydrochloride market are UCB Pharma SA, Pfizer Inc., J & J, Mylan, Teva, HUAPONT Pharm, Hunan Jiudian Pharmaceutical, Lunan Pharmaceutical, Jubilant Life Sciences, Amneal. North America region is expected to register significant growth owing to new product launches and technology advancements by leading players in the market. Europe market is also projected to grow considerably during the forecast period primarily due to rising research and development activities for innovative formulations by major companies.


Get More Insights Here

https://techaxen.com/understanding-synthetic-aperture-radar-technology/

https://www.newsstatix.com/cetirizine-hydrochloride-market-size-share-growth-outlook-2023/